BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23585368)

  • 1. Exome resequencing identifies potential tumor-suppressor genes that predispose to colorectal cancer.
    Smith CG; Naven M; Harris R; Colley J; West H; Li N; Liu Y; Adams R; Maughan TS; Nichols L; Kaplan R; Wagner MJ; McLeod HL; Cheadle JP
    Hum Mutat; 2013 Jul; 34(7):1026-34. PubMed ID: 23585368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing.
    Chubb D; Broderick P; Frampton M; Kinnersley B; Sherborne A; Penegar S; Lloyd A; Ma YP; Dobbins SE; Houlston RS
    J Clin Oncol; 2015 Feb; 33(5):426-32. PubMed ID: 25559809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome Sequencing Identifies Biallelic MSH3 Germline Mutations as a Recessive Subtype of Colorectal Adenomatous Polyposis.
    Adam R; Spier I; Zhao B; Kloth M; Marquez J; Hinrichsen I; Kirfel J; Tafazzoli A; Horpaopan S; Uhlhaas S; Stienen D; Friedrichs N; Altmüller J; Laner A; Holzapfel S; Peters S; Kayser K; Thiele H; Holinski-Feder E; Marra G; Kristiansen G; Nöthen MM; Büttner R; Möslein G; Betz RC; Brieger A; Lifton RP; Aretz S
    Am J Hum Genet; 2016 Aug; 99(2):337-51. PubMed ID: 27476653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.
    Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S
    J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients.
    Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P; Aaltonen LA
    Scand J Gastroenterol; 2013 Jun; 48(6):672-8. PubMed ID: 23544471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exome sequencing identifies potential novel candidate genes in patients with unexplained colorectal adenomatous polyposis.
    Spier I; Kerick M; Drichel D; Horpaopan S; Altmüller J; Laner A; Holzapfel S; Peters S; Adam R; Zhao B; Becker T; Lifton RP; Holinski-Feder E; Perner S; Thiele H; Nöthen MM; Hoffmann P; Timmermann B; Schweiger MR; Aretz S
    Fam Cancer; 2016 Apr; 15(2):281-8. PubMed ID: 26780541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas.
    Spier I; Holzapfel S; Altmüller J; Zhao B; Horpaopan S; Vogt S; Chen S; Morak M; Raeder S; Kayser K; Stienen D; Adam R; Nürnberg P; Plotz G; Holinski-Feder E; Lifton RP; Thiele H; Hoffmann P; Steinke V; Aretz S
    Int J Cancer; 2015 Jul; 137(2):320-31. PubMed ID: 25529843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate colorectal cancer predisposing gene variants in Chinese early-onset and familial cases.
    Zhang JX; Fu L; de Voer RM; Hahn MM; Jin P; Lv CX; Verwiel ET; Ligtenberg MJ; Hoogerbrugge N; Kuiper RP; Sheng JQ; Geurts van Kessel A
    World J Gastroenterol; 2015 Apr; 21(14):4136-49. PubMed ID: 25892863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Germline mutations in a DNA repair pathway are associated with familial colorectal cancer.
    Xu P; Sun D; Gao Y; Jiang Y; Zhong M; Zhao G; Chen J; Wang Z; Liu Q; Hong J; Chen H; Chen YX; Fang JY
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34549727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1.
    Buchanan DD; Stewart JR; Clendenning M; Rosty C; Mahmood K; Pope BJ; Jenkins MA; Hopper JL; Southey MC; Macrae FA; Winship IM; Win AK
    Genet Med; 2018 Aug; 20(8):890-895. PubMed ID: 29120461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance.
    Bellido F; Pineda M; Aiza G; Valdés-Mas R; Navarro M; Puente DA; Pons T; González S; Iglesias S; Darder E; Piñol V; Soto JL; Valencia A; Blanco I; Urioste M; Brunet J; Lázaro C; Capellá G; Puente XS; Valle L
    Genet Med; 2016 Apr; 18(4):325-32. PubMed ID: 26133394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The somatic POLE P286R mutation defines a unique subclass of colorectal cancer featuring hypermutation, representing a potential genomic biomarker for immunotherapy.
    Ahn SM; Ansari AA; Kim J; Kim D; Chun SM; Kim J; Kim TW; Park I; Yu CS; Jang SJ
    Oncotarget; 2016 Oct; 7(42):68638-68649. PubMed ID: 27612425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer.
    Elsayed FA; Kets CM; Ruano D; van den Akker B; Mensenkamp AR; Schrumpf M; Nielsen M; Wijnen JT; Tops CM; Ligtenberg MJ; Vasen HF; Hes FJ; Morreau H; van Wezel T
    Eur J Hum Genet; 2015 Aug; 23(8):1080-4. PubMed ID: 25370038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.
    Palles C; Cazier JB; Howarth KM; Domingo E; Jones AM; Broderick P; Kemp Z; Spain SL; Guarino E; Salguero I; Sherborne A; Chubb D; Carvajal-Carmona LG; Ma Y; Kaur K; Dobbins S; Barclay E; Gorman M; Martin L; Kovac MB; Humphray S; ; ; Lucassen A; Holmes CC; Bentley D; Donnelly P; Taylor J; Petridis C; Roylance R; Sawyer EJ; Kerr DJ; Clark S; Grimes J; Kearsey SE; Thomas HJ; McVean G; Houlston RS; Tomlinson I
    Nat Genet; 2013 Feb; 45(2):136-44. PubMed ID: 23263490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutations and phenotypic associations identified through APC, MUTYH, NTHL1, POLD1, POLE gene analysis in Indian Familial Adenomatous Polyposis cohort.
    Khan N; Lipsa A; Arunachal G; Ramadwar M; Sarin R
    Sci Rep; 2017 May; 7(1):2214. PubMed ID: 28533537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of adenomatous polyposis coli (APC) gene mutations in the pathogenesis of colorectal cancer; current status and perspectives.
    Aghabozorgi AS; Bahreyni A; Soleimani A; Bahrami A; Khazaei M; Ferns GA; Avan A; Hassanian SM
    Biochimie; 2019 Feb; 157():64-71. PubMed ID: 30414835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel mutations by exome sequencing in African American colorectal cancer patients.
    Ashktorab H; Daremipouran M; Devaney J; Varma S; Rahi H; Lee E; Shokrani B; Schwartz R; Nickerson ML; Brim H
    Cancer; 2015 Jan; 121(1):34-42. PubMed ID: 25250560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low frequency of POLD1 and POLE exonuclease domain variants in patients with multiple colorectal polyps.
    Elsayed FA; Tops CMJ; Nielsen M; Ruano D; Vasen HFA; Morreau H; J Hes F; van Wezel T
    Mol Genet Genomic Med; 2019 Apr; 7(4):e00603. PubMed ID: 30827058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. POLE somatic mutations in advanced colorectal cancer.
    Guerra J; Pinto C; Pinto D; Pinheiro M; Silva R; Peixoto A; Rocha P; Veiga I; Santos C; Santos R; Cabreira V; Lopes P; Henrique R; Teixeira MR
    Cancer Med; 2017 Dec; 6(12):2966-2971. PubMed ID: 29072370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
    Crabtree M; Sieber OM; Lipton L; Hodgson SV; Lamlum H; Thomas HJ; Neale K; Phillips RK; Heinimann K; Tomlinson IP
    Oncogene; 2003 Jul; 22(27):4257-65. PubMed ID: 12833148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.